mHealth Mindfulness Intervention for Pregnant Black and Latina Women at Risk of Postpartum Depression
Key facts
- Who runs it
- Kaiser Permanente
- Where
- Oakland, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- Phase
- Phase 3
- People taking part
- 600 people, planned
- Started
- 14 Jun 2022
- Ended
- Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Stress reduction program 'A'
- Stress reduction program 'B'
- Record updated
- 5 August 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age ≥18 years
- Current Kaiser Permanente Permanente Northern California (KPNC) member
- Pregnant woman receiving prenatal care at KPNC
- Gestational age <30 weeks
- Singleton pregnancy
- Self-identify as Black and/or Latina
- Moderate to moderately severe depressive symptoms (PHQ-9 score between 10 and 19) and no indication of suicidality
- Owns a device with internet access
- English- or Spanish-speaking
Who cannot take part
- Regular stress reduction practice with a mindfulness component (e.g., meditation or yoga more than twice a week)
- Deaf
- Blind
- Acting as gestational carrier/surrogate
Where in United States
- Kaiser Permanente Northern CaliforniaOakland, United States
About the trial
What the trial wants to find out
Postpartum depression (PPD) is associated with significant health consequences for mothers and children, and the current COVID-19 pandemic has had a major impact on the mental health of particularly vulnerable populations including pregnant Black and Latina women. There is an urgent need for evidence-based, accessible, and scalable mental health care options for these high-risk, vulnerable women. This study aims to: (a) compare the effectiveness of two digitally-delivered self-paced stress reduction programs in pregnant Black and Latina women at increased risk of PPD; and (b) examine barriers and facilitators to implementation within a large healthcare system.
The 2 groups in the trial
- InterventionTreatment being tested
Use of mHealth stress reduction program 'A' app 5-20 min daily for 6 weeks
Treatment: Stress reduction program 'A'
- Active controlExisting treatment, for comparison
Use of mHealth stress reduction program 'B' app 5-20 min daily for 6 weeks
Treatment: Stress reduction program 'B'
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Record updated
- 5 August 2025